Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M11,749Revenue $M4,038Net Margin (%)9.9Altman Z-Score4.4
Enterprise Value $M11,404EPS $1.2Operating Margin %12.9Piotroski F-Score6
P/E(ttm)29.5Beneish M-Score-2.6Pre-tax Margin (%)11.9Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %8.0Quick Ratio3.2Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %-7.2Current Ratio3.8Lower Leverage y-yN
Price/Free Cash Flow30.2y-y EBITDA Growth Rate %10.7ROA % (ttm)5.0Higher Current Ratio y-yY
Dividend Yield %1.2PEG--ROE % (ttm)9.1Less Shares Outstanding y-yY
Payout Ratio %31.0Shares Outstanding M332ROIC % (ttm)12.1Gross Margin Increase y-yY

Gurus Latest Trades with A

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMario Gabelli 2015-12-31 Add$34.67 - $42.36
($38.85)
$ 35.37-9%Add 5.61%184,600
AVanguard Health Care Fund 2015-09-30 Add0.1%$33.37 - $41
($37.84)
$ 35.37-7%Add 19.77%8,001,210
AJoel Greenblatt 2015-09-30 Add0.06%$33.37 - $41
($37.84)
$ 35.37-7%Add 77.32%400,556
AJohn Keeley 2015-09-30 Reduce-0.01%$33.37 - $41
($37.84)
$ 35.37-7%Reduce -3.65%162,000
ARon Baron 2015-09-30 Reduce$33.37 - $41
($37.84)
$ 35.37-7%Reduce -20.42%23,000
AChris Davis 2015-09-30 Reduce$33.37 - $41
($37.84)
$ 35.37-7%Reduce -3.09%69,007
AMario Gabelli 2015-09-30 Add$33.37 - $41
($37.84)
$ 35.37-7%Add 4.86%174,800
AChris Davis 2015-06-30 Reduce-0.41%$38.58 - $43.55
($41.51)
$ 35.37-15%Reduce -97.57%71,209
AVanguard Health Care Fund 2015-06-30 Add0.08%$38.58 - $43.55
($41.51)
$ 35.37-15%Add 18.78%6,680,210
AJoel Greenblatt 2015-06-30 Buy 0.07%$38.58 - $43.55
($41.51)
$ 35.37-15%New holding225,893
AMario Gabelli 2015-06-30 Add0.01%$38.58 - $43.55
($41.51)
$ 35.37-15%Add 25.72%166,700
AJohn Keeley 2015-06-30 Add0.01%$38.58 - $43.55
($41.51)
$ 35.37-15%Add 8.31%168,130
ARon Baron 2015-06-30 Reduce$38.58 - $43.55
($41.51)
$ 35.37-15%Reduce -14.75%28,900
AJohn Keeley 2015-03-31 Add0.07%$37.77 - $42.7
($40.45)
$ 35.37-13%Add 119.69%155,230
AMario Gabelli 2015-03-31 Buy 0.03%$37.77 - $42.7
($40.45)
$ 35.37-13%New holding132,600
AJoel Greenblatt 2015-03-31 Sold Out -0.0019%$37.77 - $42.7
($40.45)
$ 35.37-13%Sold Out0
AChris Davis 2015-03-31 Reduce$37.77 - $42.7
($40.45)
$ 35.37-13%Reduce -1.22%2,933,345
AJoel Greenblatt 2014-12-31 Reduce-0.21%$36.977 - $42.74
($40.37)
$ 35.37-12%Reduce -98.44%5,790
AFirst Eagle Investment 2014-12-31 Sold Out -0.16%$36.977 - $42.74
($40.32)
$ 35.37-12%Sold Out0
AJohn Keeley 2014-12-31 Add0.02%$36.977 - $42.74
($40.32)
$ 35.37-12%Add 44.68%70,660
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

A is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


A: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KOH BOON HWEEDirector 2015-06-29Sell5,000$39.61-10.7view
Doak MarkSr. Vice President 2015-06-26Sell7,938$40.01-11.6view
HERBOLD ROBERT JDirector 2015-06-25Sell8,870$40-11.58view
McMullen Michael R.CEO and President 2015-04-14Sell43,130$42.72-17.21view
RAND A BARRYDirector 2015-03-10Sell8,870$40.95-13.63view
CLARK PAUL NDirector 2015-03-04Sell37,973$41.87-15.52view
Huber Marie OhSr VP, General Counsel & Sec. 2015-03-03Sell107,984$42.26-16.3view
Kaltenbach PatrickSr Vice President 2015-03-03Sell1,149$42.41-16.6view
Grau DominiqueSenior Vice President 2015-03-02Sell10,949$42.63-17.03view
HIRSCH DIDIERSr. VP and CFO 2015-02-25Sell55,243$42.4-16.58view

Quarterly/Annual Reports about A:

News about A:

Articles On GuruFocus.com
Agilent, Apple and Canadian Pacific Are Among Larry Robbins' New Buys Dec 22 2015 
Should You Wait to Bet on Agilent Technologies? Dec 20 2015 
Larry Robbins Buys Cigna, Monsanto and Sells Out McDonald's Dec 09 2015 
Agilent Technologies Drop Means Buy Now Aug 27 2015 
Why Agilent Technologies is a "Hold" Jun 17 2015 
Buy the Keysight Technologies Spinoff After the Dip Jun 17 2015 
Garmin: A Bargain for Patient Investors Apr 30 2015 
Weekly 52-Week Highs Highlight: ADS, CHT, A, KYO, LFC Apr 12 2015 
Agilent Has Focused on Several Strategic Actions Mar 20 2014 
Chris Davis' Davis Funds 2013 Portfolio Managers Update Feb 27 2014 

More From Other Websites
Finding Value in These Names -- Agilent Technologies, Exact Sciences, Thermo Fisher Scientific, and... Feb 08 2016
[$$] Agilent Sues Start-Up Over Trade Secrets Feb 04 2016
San Francisco startup sued by Agilent over alleged theft of trade secrets Feb 04 2016
The Daily Startup: Agilent Sues Startup Twist Bioscience Feb 04 2016
Agilent sues startup Twist Bioscience over trade secrets Feb 03 2016
Disney’s Business Segments: Expectations for Fiscal 2016 Jan 29 2016
Disney to Continue Share Repurchase Program and Increase Capex Jan 29 2016
Agilent Technologies Wins Award for Innovation in Liquid Chromatography Jan 27 2016
Agilent Technologies Wins Award for Innovation in Liquid Chromatography Jan 27 2016
Agilent Technologies to Host Webcast of First-Quarter Fiscal Year 2016 Financial Results Conference... Jan 26 2016
Agilent Technologies to Host Webcast of First-Quarter Fiscal Year 2016 Financial Results Conference... Jan 26 2016
Netflix Continues Ramping Up Its Original Programming in 2016 Jan 26 2016
Agilent Technologies Showcases New Solutions at Biopharmaceutical Symposium Jan 26 2016
Agilent Technologies Showcases New Solutions at Biopharmaceutical Symposium Jan 26 2016
Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic... Jan 25 2016
Agilent Technologies Extends Agreement with PerkinElmer on Bioanalyzer Chips Jan 19 2016
Agilent Technologies Extends Agreement with PerkinElmer on Bioanalyzer Chips Jan 19 2016
Agilent Appoints Tang as SVP, General Counsel and Secretary Jan 11 2016
Seahorse Bioscience XF Technology Reaches 500th Citation in Cancer Research Jan 11 2016
Thermo Fisher Scientific’s Latest Analyst Recommendations Jan 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK